Long-term clinical course of decompensated alcoholic cirrhosis: A prospective study of 165 patients

Journal of Clinical Gastroenterology

Volumn 45, Issue 10, 2011, Pages 906-911

  Alvarez, Marco Antonio ^a,b   Cirera, Isabel ^b,c   Solà, Ricard ^b,c   Bargalló, Ana ^a,b   Morillas, Rosa Maria ^a,b,d   Planas, Ramon ^a,b,d  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Child Pugh score; cirrhosis; hepatic encephalopathy; hepatocellular carcinoma; model for end stage liver disease; prognosis; survival

Indexed keywords

ALBUMIN; ALCOHOL;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ARTICLE; ASCITES; BACTERIAL PERITONITIS; DECOMPENSATED LIVER CIRRHOSIS; DISEASE COURSE; ECHOGRAPHY; END STAGE LIVER DISEASE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL;

AGED; ALCOHOL DRINKING; ASCITES; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; SURVIVAL RATE; TEMPERANCE;

EID: 80054107289     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3182284e13     Document Type: Article

References (38)

1. Yoon YH, Yi HY. Surveillance report #83: liver cirrhosis mortality in the United States, 1970-2005. National Institute on Alcohol and Alcoholism Web site. Available at http://pubs. niaaa.nih.gov/publications/surveillance83/ Cirr05.htm. [Accessed August 2009.]
2. Adam R, McMaster P, O'Grady JG, et al. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl. 2003;9:1231-1243.
3. D'Amico G, Morabito A, Pagliaro L, et al. Marubini E. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci. 1986;31:468-475.
4. Gines P, Quintero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7:122-128.
5. Powell WJ Jr, Klatskin G. Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. Am J Med. 1968;44:406-420.
6. Saunders JB, Walters JR, Davies AP, et al. A 20-year prospective study of cirrhosis. Br Med J (Clin Res Ed). 1981;282:263-266.
7. Ostapowicz G, Watson KJ, Locarnini SA, et al. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology. 1998;27:1730-1735.
8. Corrao G, Arico S. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology. 1998;27:914-919.
9. De Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43:167-176.
10. Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol. 2000;32:142-153.
11. Maddrey WC, Boitnott JK, Bedine MS, et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 1978;75:193-199.
12. Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Practice Guidelines Committee of American Association for Study of Liver Diseases; Practice Parameters Committee of American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol. 2007;102:2086-2102.
13. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464-470.
14. Bruix J, Sherman M. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-1236.
15. Planas R, Balleste B, Alvarez MA, et al. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients. J Hepatol. 2004;40:823-830.
16. Propst A, Propst T, Zangerl G, et al. Prognosis and life expectancy in chronic liver disease. Dig Dis Sci. 1995;40:1805-1815.
17. Bell H, Jahnsen J, Kittang E, et al. Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit. Scand J Gastroenterol. 2004;39:858-863.
18. Fattovich G, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective followup study of 384 patients. Gastroenterolgy. 1997;112:463-472.
19. Pineda JA, Romero-Gomez M, Diaz-Garcia F, et al. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology. 2005;41:779-789.
20. Planas R, Montoliu S, Balleste B, et al. Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol. Hepatol. 2006;4:1385-1394.
21. Talwalkar JA. Time trends in hospitalization and discharge status for cirrhosis and portal hypertension in the United States. Hepatology. 2010;52:1862.
22. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341:403-409.
23. McCormick PA, O'Keefe C. Improving prognosis following a first variceal haemorrhage over four decades. Gut. 2001;49:682-685.
24. Bernard B, Grange JD, Khac EN, et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology. 1999;29:1655-1661.
25. Gines P, Rimola A, Planas R, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology. 1990;12(4 Pt 1):716-724.
26. Jepsen P, Ott P, Andersen PK, et al. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology. 2010;51:1675-1682.
27. Fleming KM, Aithal GP, Card TR, et al. The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study. Aliment Pharmacol Ther. 2010;32:1343-1350.
28. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217-231.
29. Schenker S. Alcoholic liver disease: evaluation of natural history and prognostic factors. Hepatology. 1984;4(1 Suppl):36S-43S.
30. Borowsky SA, Strome S, Lott E. Continued heavy drinking and survival in alcoholic cirrhotics. Gastroenterology. 1981;80:1405-1409.
31. Pessione F, Ramond MJ, Peters L, et al. Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence. Liver Int. 2003;23:45-53.
32. Berlakovich GA. Wasting your organ with your lifestyle and receiving a new one? Ann Transplant. 2005;1038-1043.
33. Veldt BJ, Laine F, Guillygomarch A, et al. Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing. J Hepatol. 2002;36:93-98.
34. Liver and Intestine Transplantation in the United States 1998-2007. Available at http://www.ustransplant.org. Accessed September 2010.
35. O'Grady JG. Liver transplantation alcohol related liver disease: (deliberately) stirring a hornet's nest! Gut. 2006;55:1529-1531.
36. Christensen E. Prognostic models including the Child-Pugh, MELD and Mayo risk scores: where are we and where should we go? J Hepatol. 2004;41:344-350.
37. Cholongitas E, Papatheodoridis GV, Vangeli M, et al. Systematic review: the model for end-stage liver disease: should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Pharmacol Ther. 2005;22:1079-1089.
38. Angermayr B, Cejna M, Karnel F, et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut. 2003;52:879-885.